Big Pharma and some financial services companies could be hurt by midterms: Beacon Policy's Myrow

Steven Myro is the founder of Beacon Policy Advisors. When you're when you're looking at those probabilities on Koshi, let's just assume the the crowd wisdom is right and this is the way it's going to go. Stephen, what do you think that that investors should take away from from that.>> Yeah, thanks for having me. So, I think the most interesting thing from us at Beacon Policy Advisors talking to our uh institutional investment clients that they didn't fully appreciate is how oversight is likely to work once ...